ArticleBulletin of experimental biology and medicine2025
Pharmacobiochemical Analysis of the Cytoprotective Action of New 5-Androstendiol Derivatives.
Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
5-Androstenediol esters, dibutanoate and dipropionate, were synthesized as prototypes of effective cytoprotectors with prolonged action. The cytoprotective effect of the new 5-androstenediol derivatives was assessed in human lung and skin fibroblasts and human blood mononuclear cells exposed to UV radiation. 5-Androstenediol esters showed a regenerating, cytoprotective effect on different types of fibroblasts, but not on human peripheral blood mononuclear cells. The DNA comet assay revealed no genotoxic effect of the new steroids on the mononuclear fraction of human blood, which indicates their safety. The cytoprotective activity of 5-androstenediol dibutanoate and dipropionate in human fibroblasts attests to their possible use for creating ointments and liniments for the treatment of skin injuries requiring regeneration (including irradiation damage).
Indexed as
Identifiers
40877650What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.